Jun 2025· bioRxiv· Vol 54· 2 citations· 99 references
MedicineBiology
TL;DR
SpliceImpactR is introduced, an open-source tool that systematically identifies RNA isoform switches—including alternative first and last exons, exon skipping, intron retention, hybrid exons, and splice site variation—across the human transcriptome, and predicts their impact on encoded proteins.
Abstract
Alternative RNA processing is a key regulator of gene expression, driving transcript and proteomic diversity essential for cell function. However, the precise impacts of different alternative RNA processing events on protein function remain poorly understood. Here, we introduce SpliceImpactR, an open-source tool that systematically identifies RNA isoform switches—including alternative first and last exons, exon skipping, intron retention, hybrid exons, and splice site variation—across the human transcriptome, and predicts their impact on encoded proteins. We find that intron retention and hybrid exons frequently alter the coding potential of transcripts. Strikingly, when both isoforms remain protein-coding, 87% of alternative RNA processing events result in substantial changes to the protein sequence. Among these, alternative last exons drive the largest changes, frequently disrupting protein-protein interactions. Across human tissues, alternative first exons drive the largest relative changes in proteins, often resulting in tissue-specific protein domains. Notably, frameshifts introduced by alternative splicing are often rescued by co-regulated alternative downstream exons, suggesting a buffering mechanism in isoform regulation. Moreover, we show that alternative splicing exhibits gradual, tissue-specific variation, rather than binary on/off behavior, enabling conserved regulation of protein domains across tissues. Together, our results provide a proteome-wide view of splicing regulation, uncovering widespread, context-dependent impacts of alternative splicing on the human proteome.
RNA splicing shapes neuronal identity and disease risk, yet current maps lack the developmental resolution and depth to resolve this complexity. Here, we integrate deep long-read RNA sequencing and proteomics in induced pluripotent stem cell-derived cortical neurons to generate a high-resolution proteogenomic atlas of...
N. Xu, Katherine M. Rynard, E. Radley et al.· Nature Communications· 1 citation
This review integrates the molecular logic of splice-site selection with the cancer-specific mechanisms that perturb it, summarizes representative isoform switches across the hallmarks of cancer, evaluates emerging technologies and clinical biomarkers, and discusses the opportunities and constraints of translating spli...
This review describes how spliceosome assembly, splicing regulatory elements, splicing factors, epigenetic modifications, and post-transcriptional processes determine splice-site selection and suggests that safe clinical translation will require greater selectivity, reduced off-target toxicity, and preservation of esse...
Huining Huang, Yao Yu, Qian Zhou et al.· Molecular Biomedicine· 0 citations
Dynamic alternative splicing programs drive tissue specification and organismal development. Here, we present the most comprehensive, tissue-resolved alternative splicing dataset in Caenorhabditis elegans to date, spanning three major tissue types from early embryogenesis to adulthood. We uncovered broad developmental...
Bina Koterniak, Ernest Liang, Michael Zoberman et al.· bioRxiv· 0 citations
Alternative splicing represents a major source of potential evolutionary novelty in protein sequence. Despite this, relatively few studies have investigated the functional impacts of human-specific alternative splicing. Here, we analyze RNA-sequencing data from nine iPSC-derived cell types and identify dozens of human...
Alexander L. Starr, A. Villalba, Jenna Rever et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.